Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: A case report

被引：11

作者：

Lefebvre N. ^{[1
]}

Forestier E. ^{[1
]}

Farhi D. ^{[2
]}

Mahsa M.Z. ^{[1
]}

Remy V. ^{[1
]}

Lesens O. ^{[1
]}

Christmann D. ^{[1
]}

Hansmann Y. ^{[1
]}

机构：

[1] Department of Infectious Diseases and Tropical Medicine, Teaching Hospital, Strasbourg

[2] Department of Dermatology, Tarnier Hospital, Paris

来源：

Journal of Medical Case Reports | / 1卷 / 1期

关键词：

Eosinophilia; Allopurinol; Minocycline; Brain Edema; Cerebral Edema;

D O I：

10.1186/1752-1947-1-22

中图分类号：

学科分类号：

摘要：

Background: Hypersentivity Syndrome (HS) may be a life-threatening condition. It frequently presents with fever, rash, eosinophilia and systemic manifestations. Mortality can be as high as 10% and is primarily due to hepatic failure. We describe what we believe to be the first case of minocycline-induced HS with accompanying lymphocytic meningitis and cerebral edema reported in the literature. Case presentation: A 31-year-old HIV-positive female of African origin presented with acute fever, lymphocytic meningitis, brain edema, rash, eosinophilia, and cytolytic hepatitis. She had been started on minocycline for inflammatory acne 21 days prior to the onset of symptoms. HS was diagnosed clinically and after exclusion of infectious causes. Minocycline was withdrawn and steroids were administered from the second day after presentation because of the severity of the symptoms. All signs resolved by the seventh day and steroids were tailed off over a period of 8 months. Conclusion: Clinicians should maintain a high index of suspicion for serious adverse reactions to minocycline including lymphocytic meningitis and cerebral edema among HIV-positive patients, especially if they are of African origin. Safer alternatives should be considered for treatment of acne vulgaris. Early recognition of the symptoms and prompt withdrawal of the drug are important to improve the outcome. © 2007 Lefebvre et al; licensee BioMed Central Ltd.

引用

共 10 条

[1]

Knowles S.R., Shapiro L., Shear N.H., Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature, Arch Dermatol, 132, 8, pp. 934-939, (1996)

[2]

Bernier C., Dreno B., Minocycline, Ann Dermatol Venereol, 128, 5, pp. 627-637, (2001)

[3]

Roujeau J.C., Stern R.S., Severe adverse cutaneous reactions to drugs, N Engl J Med, 331, 19, pp. 1272-1285, (1994)

[4]

Sapadin A.N., Fleischmajer R., Tetracyclines: Nonantibiotic properties and their clinical implications, J Am Acad Dermatol, 54, 2, pp. 258-265, (2006)

[5]

Shapiro L.E., Knowles S.R., Shear N.H., Comparative safety of tetracycline, minocycline, and doxycycline, Arch Dermatol, 133, pp. 1224-1230, (1997)

[6]

Chiu A.M., Chuenkongkaew W.L., Cornblath W.T., Trobe J.D., Digre K.B., Dotan S.A., Musson K.H., Eggenberger E.R., Minocycline treatment and pseudotumor cerebri syndrome, Am J Ophthalmol, 126, 1, pp. 116-121, (1998)

[7]

Grasset L., Guy C., Ollagnier M., Cyclines and acne: Pay attention to adverse drug reactions! A recent literature review, Rev Med Interne, 24, 5, pp. 305-316, (2003)

[8]

Parneix-Spake A., Bastuji-Garin S., Lobut J.B., Erner J., Guyet-Rousset P., Revuz J., Roujeau J.C., Minocycline as possible cause of severe and protracted hypersensitivity drug reaction, Arch Dermatol, 131, 4, pp. 490-491, (1995)

[9]

Mills Jr. R.M., Severe hypersensitivity reactions associated with allopurinol, Jama, 216, 5, pp. 799-802, (1971)

[10]

MacNeil M., Haase D.A., Tremaine R., Marrie T.J., Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: A severe adverse reaction to minocycline, J Am Acad Dermatol, 36, 2 PART 2, pp. 347-350, (1997)

← 1 →